First 3 runs free, then $50/run
    First 3 runs free, then $50/run

    Investment case

    Pacific Biosciences of California, Inc.

    PACB · 3 developments mapped · last assessed 2026-09-25

    Market Ontology has mapped 3 macro, policy, and market developments to Pacific Biosciences of California, Inc. since 2026-09-19. Each one is traced from the driver to the valuation assumption it moves, and the valuation below is run on the same engine the subscription uses.

    Last close
    Unavailable
    No published quote
    Market cap
    Unavailable
    Equity value
    Diluted shares
    Unavailable
    Latest reported
    Sector
    Unavailable
    Listing
    Unavailable
    Filings
    Unavailable
    No published filing

    Valuation

    No validated run has been published for PACB yet, so no modelled value is shown. The PACB valuation is in the public catch-up queue.

    Subscribers do not wait for the weekly cycle: they run PACB on demand, against live prices and the latest filings, and change any assumption the developments below move.

    Filed financials

    A validated filed-statement snapshot has not been published for PACB. Missing data is not estimated or replaced with scenario assumptions.

    Current case

    • Strongest support

      Ginkgo Bioworks Inks $31M Contract with SaponiQx for AI Vaccine Adjuvants

      Increased demand for genomic sequencing and synthetic biology tools and consumables as the sector grows and secures more funding.

      · Moves market size growth, equipment utilization

    • Open question

      Twist Bioscience Surges 31% on Eli Lilly AI Drug Discovery Deal

      Increased investor interest in genomics/synthetic biology tools, potential for similar partnerships.

      · Moves market growth for genomics tools, investor sentiment towards biotech innovation

    What changed, by assumption

    Market growth for genomics tools
    • 2026-09-20Twist Bioscience Surges 31% on Eli Lilly AI Drug Discovery Deal
    Investor sentiment
    • 2026-09-19Twist Bioscience Partners with Eli Lilly on AI-Powered TuneLab Platform
    Market size growth
    • 2026-09-25Ginkgo Bioworks Inks $31M Contract with SaponiQx for AI Vaccine Adjuvants

    Event impact log

    Full ledger →
    DateMechanismDirectionHorizonImpact
    2026-09-25Ginkgo Bioworks Inks $31M Contract with SaponiQx for AI Vaccine AdjuvantsBullish3-12m0.20
    2026-09-20Twist Bioscience Surges 31% on Eli Lilly AI Drug Discovery Dealwatch3-12m0.30
    2026-09-19Twist Bioscience Partners with Eli Lilly on AI-Powered TuneLab Platformwatch3-12m0.30